MIGUEL ÁNGEL
CALLEJA HERNÁNDEZ
Chercheur dans le période 2016-2017
CRISTINA
PÉREZ RAMÍREZ
PROFESORA AYUDANTE DOCTORA
Publications dans lesquelles il/elle collabore avec CRISTINA PÉREZ RAMÍREZ (17)
2021
-
Association between polymorphisms in the vitamin D receptor and susceptibility to multiple sclerosis
Pharmacogenetics and Genomics, Vol. 31, Núm. 2, pp. 40-47
-
Genetic polymorphisms on the effectiveness or safety of breast cancer treatment: Clinical relevance and future perspectives
Mutation Research - Reviews in Mutation Research, Vol. 788
-
Pharmacogenetic Predictors of Response to Interferon Beta Therapy in Multiple Sclerosis
Molecular Neurobiology, Vol. 58, Núm. 9, pp. 4716-4726
-
Therapeutic value of single nucleotide polymorphisms on the efficacy of new therapies in patients with multiple sclerosis
Journal of Personalized Medicine, Vol. 11, Núm. 5
2020
-
Association of ABCB1 and VEGFA gene polymorphisms with breast cancer susceptibility and prognosis
Pathology Research and Practice, Vol. 216, Núm. 4
-
Effect of genetic polymorphisms on therapeutic response in multiple sclerosis relapsing-remitting patients treated with interferon-beta
Mutation Research - Reviews in Mutation Research, Vol. 785
2019
-
Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients
Pharmacogenomics Journal, Vol. 19, Núm. 2, pp. 164-177
2018
-
Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer
Pathology Research and Practice, Vol. 214, Núm. 1, pp. 44-52
2017
-
Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer
Mutation Research - Reviews in Mutation Research, Vol. 771, pp. 32-58
-
Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer
Pharmacogenetics and Genomics, Vol. 27, Núm. 12, pp. 438-444
-
Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer
Surgical Oncology, Vol. 26, Núm. 3, pp. 278-285
2016
-
Liquid biopsy in early stage lung cancer
Translational Lung Cancer Research, Vol. 5, Núm. 5, pp. 517-524
-
Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients
Pharmacological Research, Vol. 111, pp. 877-884
2015
-
MET/HGF targeted drugs as potential therapeutic strategies in non-small cell lung cancer
Pharmacological Research, Vol. 102, pp. 90-106
-
MET: A new promising biomarker in non-small-cell lung carcinoma
Pharmacogenomics, Vol. 16, Núm. 6, pp. 631-647
-
PTEN and PI3K/AKT in non-small-cell lung cancer
Pharmacogenomics, Vol. 16, Núm. 16, pp. 1843-1862
2013
-
Pharmacogenetics of oral anticoagulants
Omics for Personalized Medicine (Springer India), pp. 435-467